MODULAR TRANSFECTION SYSTEMS BASED ON NUCLEOPROTEIN FILAMENTS

The present invention relates to a method for transfection of cells using at least one protein capable of forming nucleoprotein filaments, wherein the protein is initially modified with at least one functional component which influences one or more steps of the transfection, the nucleic acid to be t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ORTMANN, BODO, ALTROGGE, LUDGER, HEIN, KATHARINA, CHRISTINE, RAINER, TURBANSKI, TAMARA, LORBACH, ELKE, MALES, TATJANA, GREMSE, MARION, KLAES, ANDREA, RIEMEN, GUDULA, HELFRICH, JULIANA, SCHMIDT, HANNS-MARTIN, SIEBENKOTTEN, GREGOR, LENZ, DIETMAR, BROSTERHUS, HELMUT
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ORTMANN, BODO
ALTROGGE, LUDGER
HEIN, KATHARINA
CHRISTINE, RAINER
TURBANSKI, TAMARA
LORBACH, ELKE
MALES, TATJANA
GREMSE, MARION
KLAES, ANDREA
RIEMEN, GUDULA
HELFRICH, JULIANA
SCHMIDT, HANNS-MARTIN
SIEBENKOTTEN, GREGOR
LENZ, DIETMAR
BROSTERHUS, HELMUT
description The present invention relates to a method for transfection of cells using at least one protein capable of forming nucleoprotein filaments, wherein the protein is initially modified with at least one functional component which influences one or more steps of the transfection, the nucleic acid to be transfected is then loaded with the modified protein, whereby the nucleic acid and the protein form a filament-like complex, and this complex is finally added to the cells to be transfected. The invention further relates to a transfection agent consisting of nucleoprotein filaments (NPF), with at least one nucleoprotein filament-forming protein being modified with at least one functional component for the transfection. Furthermore, the present invention relates to the use of the transfection agent according to the invention for producing a drug for gene therapeutic treatment of humans and animals. The present inventions also includes corresponding pharmaceutical preparations, especially for use in gene therapy as well as the use of such transfection agents as component in kits.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP1427837B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP1427837B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP1427837B13</originalsourceid><addsrcrecordid>eNrjZLD19XcJ9XEMUggJcvQLdnN1DvH091MIjgwOcfUNVnByDHZ1UQAK-IU6-7j6BwT5h7h6-im4efo4-rr6hQTzMLCmJeYUp_JCaW4GBTfXEGcP3dSC_PjU4oLE5NS81JJ41wBDEyNzC2NzJ0NjIpQAABUaKfA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MODULAR TRANSFECTION SYSTEMS BASED ON NUCLEOPROTEIN FILAMENTS</title><source>esp@cenet</source><creator>ORTMANN, BODO ; ALTROGGE, LUDGER ; HEIN, KATHARINA ; CHRISTINE, RAINER ; TURBANSKI, TAMARA ; LORBACH, ELKE ; MALES, TATJANA ; GREMSE, MARION ; KLAES, ANDREA ; RIEMEN, GUDULA ; HELFRICH, JULIANA ; SCHMIDT, HANNS-MARTIN ; SIEBENKOTTEN, GREGOR ; LENZ, DIETMAR ; BROSTERHUS, HELMUT</creator><creatorcontrib>ORTMANN, BODO ; ALTROGGE, LUDGER ; HEIN, KATHARINA ; CHRISTINE, RAINER ; TURBANSKI, TAMARA ; LORBACH, ELKE ; MALES, TATJANA ; GREMSE, MARION ; KLAES, ANDREA ; RIEMEN, GUDULA ; HELFRICH, JULIANA ; SCHMIDT, HANNS-MARTIN ; SIEBENKOTTEN, GREGOR ; LENZ, DIETMAR ; BROSTERHUS, HELMUT</creatorcontrib><description>The present invention relates to a method for transfection of cells using at least one protein capable of forming nucleoprotein filaments, wherein the protein is initially modified with at least one functional component which influences one or more steps of the transfection, the nucleic acid to be transfected is then loaded with the modified protein, whereby the nucleic acid and the protein form a filament-like complex, and this complex is finally added to the cells to be transfected. The invention further relates to a transfection agent consisting of nucleoprotein filaments (NPF), with at least one nucleoprotein filament-forming protein being modified with at least one functional component for the transfection. Furthermore, the present invention relates to the use of the transfection agent according to the invention for producing a drug for gene therapeutic treatment of humans and animals. The present inventions also includes corresponding pharmaceutical preparations, especially for use in gene therapy as well as the use of such transfection agents as component in kits.</description><language>eng ; fre ; ger</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; COMPOSITIONS THEREOF ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; TESTING ; VINEGAR ; WINE</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20111026&amp;DB=EPODOC&amp;CC=EP&amp;NR=1427837B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20111026&amp;DB=EPODOC&amp;CC=EP&amp;NR=1427837B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ORTMANN, BODO</creatorcontrib><creatorcontrib>ALTROGGE, LUDGER</creatorcontrib><creatorcontrib>HEIN, KATHARINA</creatorcontrib><creatorcontrib>CHRISTINE, RAINER</creatorcontrib><creatorcontrib>TURBANSKI, TAMARA</creatorcontrib><creatorcontrib>LORBACH, ELKE</creatorcontrib><creatorcontrib>MALES, TATJANA</creatorcontrib><creatorcontrib>GREMSE, MARION</creatorcontrib><creatorcontrib>KLAES, ANDREA</creatorcontrib><creatorcontrib>RIEMEN, GUDULA</creatorcontrib><creatorcontrib>HELFRICH, JULIANA</creatorcontrib><creatorcontrib>SCHMIDT, HANNS-MARTIN</creatorcontrib><creatorcontrib>SIEBENKOTTEN, GREGOR</creatorcontrib><creatorcontrib>LENZ, DIETMAR</creatorcontrib><creatorcontrib>BROSTERHUS, HELMUT</creatorcontrib><title>MODULAR TRANSFECTION SYSTEMS BASED ON NUCLEOPROTEIN FILAMENTS</title><description>The present invention relates to a method for transfection of cells using at least one protein capable of forming nucleoprotein filaments, wherein the protein is initially modified with at least one functional component which influences one or more steps of the transfection, the nucleic acid to be transfected is then loaded with the modified protein, whereby the nucleic acid and the protein form a filament-like complex, and this complex is finally added to the cells to be transfected. The invention further relates to a transfection agent consisting of nucleoprotein filaments (NPF), with at least one nucleoprotein filament-forming protein being modified with at least one functional component for the transfection. Furthermore, the present invention relates to the use of the transfection agent according to the invention for producing a drug for gene therapeutic treatment of humans and animals. The present inventions also includes corresponding pharmaceutical preparations, especially for use in gene therapy as well as the use of such transfection agents as component in kits.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>COMPOSITIONS THEREOF</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLD19XcJ9XEMUggJcvQLdnN1DvH091MIjgwOcfUNVnByDHZ1UQAK-IU6-7j6BwT5h7h6-im4efo4-rr6hQTzMLCmJeYUp_JCaW4GBTfXEGcP3dSC_PjU4oLE5NS81JJ41wBDEyNzC2NzJ0NjIpQAABUaKfA</recordid><startdate>20111026</startdate><enddate>20111026</enddate><creator>ORTMANN, BODO</creator><creator>ALTROGGE, LUDGER</creator><creator>HEIN, KATHARINA</creator><creator>CHRISTINE, RAINER</creator><creator>TURBANSKI, TAMARA</creator><creator>LORBACH, ELKE</creator><creator>MALES, TATJANA</creator><creator>GREMSE, MARION</creator><creator>KLAES, ANDREA</creator><creator>RIEMEN, GUDULA</creator><creator>HELFRICH, JULIANA</creator><creator>SCHMIDT, HANNS-MARTIN</creator><creator>SIEBENKOTTEN, GREGOR</creator><creator>LENZ, DIETMAR</creator><creator>BROSTERHUS, HELMUT</creator><scope>EVB</scope></search><sort><creationdate>20111026</creationdate><title>MODULAR TRANSFECTION SYSTEMS BASED ON NUCLEOPROTEIN FILAMENTS</title><author>ORTMANN, BODO ; ALTROGGE, LUDGER ; HEIN, KATHARINA ; CHRISTINE, RAINER ; TURBANSKI, TAMARA ; LORBACH, ELKE ; MALES, TATJANA ; GREMSE, MARION ; KLAES, ANDREA ; RIEMEN, GUDULA ; HELFRICH, JULIANA ; SCHMIDT, HANNS-MARTIN ; SIEBENKOTTEN, GREGOR ; LENZ, DIETMAR ; BROSTERHUS, HELMUT</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP1427837B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2011</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>COMPOSITIONS THEREOF</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>ORTMANN, BODO</creatorcontrib><creatorcontrib>ALTROGGE, LUDGER</creatorcontrib><creatorcontrib>HEIN, KATHARINA</creatorcontrib><creatorcontrib>CHRISTINE, RAINER</creatorcontrib><creatorcontrib>TURBANSKI, TAMARA</creatorcontrib><creatorcontrib>LORBACH, ELKE</creatorcontrib><creatorcontrib>MALES, TATJANA</creatorcontrib><creatorcontrib>GREMSE, MARION</creatorcontrib><creatorcontrib>KLAES, ANDREA</creatorcontrib><creatorcontrib>RIEMEN, GUDULA</creatorcontrib><creatorcontrib>HELFRICH, JULIANA</creatorcontrib><creatorcontrib>SCHMIDT, HANNS-MARTIN</creatorcontrib><creatorcontrib>SIEBENKOTTEN, GREGOR</creatorcontrib><creatorcontrib>LENZ, DIETMAR</creatorcontrib><creatorcontrib>BROSTERHUS, HELMUT</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ORTMANN, BODO</au><au>ALTROGGE, LUDGER</au><au>HEIN, KATHARINA</au><au>CHRISTINE, RAINER</au><au>TURBANSKI, TAMARA</au><au>LORBACH, ELKE</au><au>MALES, TATJANA</au><au>GREMSE, MARION</au><au>KLAES, ANDREA</au><au>RIEMEN, GUDULA</au><au>HELFRICH, JULIANA</au><au>SCHMIDT, HANNS-MARTIN</au><au>SIEBENKOTTEN, GREGOR</au><au>LENZ, DIETMAR</au><au>BROSTERHUS, HELMUT</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MODULAR TRANSFECTION SYSTEMS BASED ON NUCLEOPROTEIN FILAMENTS</title><date>2011-10-26</date><risdate>2011</risdate><abstract>The present invention relates to a method for transfection of cells using at least one protein capable of forming nucleoprotein filaments, wherein the protein is initially modified with at least one functional component which influences one or more steps of the transfection, the nucleic acid to be transfected is then loaded with the modified protein, whereby the nucleic acid and the protein form a filament-like complex, and this complex is finally added to the cells to be transfected. The invention further relates to a transfection agent consisting of nucleoprotein filaments (NPF), with at least one nucleoprotein filament-forming protein being modified with at least one functional component for the transfection. Furthermore, the present invention relates to the use of the transfection agent according to the invention for producing a drug for gene therapeutic treatment of humans and animals. The present inventions also includes corresponding pharmaceutical preparations, especially for use in gene therapy as well as the use of such transfection agents as component in kits.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP1427837B1
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
COMPOSITIONS THEREOF
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES OF PREPARING SUCH COMPOSITIONS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
TESTING
VINEGAR
WINE
title MODULAR TRANSFECTION SYSTEMS BASED ON NUCLEOPROTEIN FILAMENTS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T22%3A24%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ORTMANN,%20BODO&rft.date=2011-10-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP1427837B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true